Check Your Eligibility
Answer a few questions to see if you may qualify for this trial.
Step 1 of 8
Have you been diagnosed with advanced melanoma (skin cancer) that has spread or come back, and has it gotten worse even after you received anti-PD-1 immunotherapy treatment?
This trial is specifically for patients whose melanoma has progressed despite anti-PD-1 treatment. This is the core disease requirement for the study.
Show original medical criteria
Histologically confirmed unresectable advanced, recurrent, or metastatic melanoma with disease progression after anti-PD-1 therapy
This is informational only — not medical advice. Always discuss eligibility with your oncologist.